N. Simmonds (London, United Kingdom), R. Gray (Edinburgh, United Kingdom), C. Schwarz (Berlin, Germany)
Correlation of physical fitness with peripheral muscle strength, physical activity levels and lung function in patients with cystic fibrosis
M. Donadio (Porto Alegre, Brazil), F. Vendrusculo (Porto Alegre, Brazil), G. Bueno (Porto Alegre, Brazil), N. Campos (Porto Alegre, Brazil), I. Silveira (Porto Alegre, Brazil), M. Gheller (Porto Alegre, Brazil), J. Heinzmann-Filho (Porto Alegre, Brazil)
|   |
Non-invasive ventilation during exercise in severe cystic fibrosis subjects: a preliminary study
R. Bellini (Verona, Italy), C. Cazzarolli (Verona, Italy)
| |
In adults with cystic fibrosis (CF), the high-resolution computed tomography (HRCT) predicts maximal exercise capacity
E. Crisafulli (Parma, Italy), E. Teopompi (Parma, Italy), S. Luceri (Parma, Italy), . Longo (Parma, Italy), P. Pagano (Parma, Italy), . Longo (Parma, Italy), A. Ielpo (Parma, Italy), M. Aiello (Parma, Italy), G. Bertorelli (Parma, Italy), N. Sverzellati (Parma, Italy), . Chetta (Parma, Italy), G. Pisi (Parma, Italy)
| |
Cardiorespiratory Fitness in an adult Norwegian Cystic Fibrosis Population
O. Torvanger (Oslo, Norway), A. Os (Oslo, Norway), O. Skjønsberg (Oslo, Norway), E. Edvardsen (Oslo, Norway)
| |
Real life experience of lumacaftor/ivacafotor in adult Phe508del homozygous cystic fibrosis patients.
G. Bonizzoni (Orbassano, Italy), M. Bellocchia (Orbassano, Italy), C. Bena (Orbassano, Italy), E. Clivati (Orbassano, Italy), C. Biglia (Orbassano, Italy), S. Demichelis (Orbassano, Italy), G. Bandelli (Orbassano, Italy), A. Grande (Orbassano, Italy), F. Traversa (Orbassano, Italy), C. Albera (Orbassano, Italy), B. Messore (Orbassano, Italy)
| |
Real-life experience of Omalizumab in adult Cystic Fibrosis patients with allergic severe asthma and Allergic Bronchopulmonary Aspergillosis
M. Bellocchia (Orbassano, Italy), G. Bonizzoni (Orbassano, Italy), C. Biglia (Orbassano, Italy), C. Bena (Orbassano, Italy), E. Clivati (Orbassano, Italy), V. Difino (Orbassano, Italy), F. Traversa (Orbassano, Italy), S. Demichelis (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy), C. Albera (Orbassano, Italy), B. Messore (Orbassano, Italy)
| |
Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation
A. Gramegna (Milan, Italy), M. Contarini (Milan, Italy), S. Aliberti (Milan, Italy), G. Sotgiu (Sassari, Italy), M. Seia (Milan, Italy), L. Porcaro (Milan, Italy), A. Colombo (Milan, Italy), N. Vanoni (Milan, Italy), F. Amati (Milan, Italy), G. Pizzamiglio (Milan, Italy), M. Di Pasquale (Milan, Italy), S. Dellafiore (Milan, Italy), M. Pappalettera (Milan, Italy), C. Castellani (Verona, Italy), B. Assael (Milan, Italy), F. Blasi (Milan, Italy)
| |
Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation
M. Contarini (Milan, Italy), A. Gramegna (Milan, Italy), S. Aliberti (Milan, Italy), G. Sotgiu (Sassari, Italy), M. Seia (Milan, Italy), L. Porcaro (Milan, Italy), A. Colombo (Milan, Italy), N. Vanoni (Milan, Italy), F. Amati (Milan, Italy), G. Pizzamiglio (Milan, Italy), M. Di Pasquale (Milan, Italy), S. Dellafiore (Milan, Italy), M. Pappalettera (Milan, Italy), C. Castellani (Verona, Italy), B. Assael (Milan, Italy), F. Blasi (Milan, Italy)
| |
A review of Lung Transplantation for Cystic Fibrosis in Ireland in 2017.
P. Grehan (Dublin, Ireland), I. Byrne (Dublin, Ireland), J. Egan (Dublin, Ireland), D. Danaher (Dublin, Ireland), H. Transplant Team (Dublin, Ireland)
| |
Macroscopic sputum quality assessments with a colour grading system in Cystic Fibrosis patients
B. Ferrari (Florence, Italy), C. Degl'Innocenti (Florence, Italy), C. Castellani (Florence, Italy), E. Masi (Florence, Italy), V. Terlizzi (Florence, Italy), M. Cavicchi (Florence, Italy), R. Guarise (Florence, Italy)
| |
Transmission-frequency of Aspergillus fumigatus in cystic fibrosis patients through coughing
T. Engel (Nijmegen, Netherlands), E. Erren (Nijmegen, Netherlands), K. Vanden Driessche (Nijmegen, Netherlands), M. Reijers (Nijmegen, Netherlands), W. Melchers (Nijmegen, Netherlands), P. Merkus (Nijmegen, Netherlands), P. Verweij (Nijmegen, Netherlands)
| |
Prospective study on clinical and immunological Aspergillus categorization in cystic fibrosis.
S. Kaufmann (Berlin, Germany), J. Röhmel (Berlin, Germany), P. Eschenhagen (Berlin, Germany), A. Mehl (Berlin, Germany), C. Meinus (Berlin, Germany), D. Staab (Berlin, Germany), V. Rickerts (Berlin, Germany), K. Seidel (Berlin, Germany), P. Bacher (Berlin, Germany), A. Scheffold (Berlin, Germany), C. Schwarz (Berlin, Germany)
| |
Pseudomonas aeruginosa eradication therapy on Cystic Fibrosis- Guideline and clinical routine
K. Einhorn (Rostock, Germany), M. Ballmann (Rostock, Germany)
| |
Treatment of atelectasis and severe mucus plugging in cystic fibrosis.
H. Elidottir (Lund, Sweden)
| |
Assessment of mental health status in primary ciliary dyskinesia and cystic fibrosis patients and their parents
S. Graziano (Rome, Italy), V. Mirra (Rome, Italy), N. Ullmann (Rome, Italy), R. Rusciano (Rome, Italy), V. Lucidi (Rome, Italy), R. Cutrera (Rome, Italy), P. Tabarini (Rome, Italy)
| |
Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis
A. Gramegna (Milan, Italy), M. Contarini (Milan, Italy), S. Aliberti (Milan, Italy), G. Sotgiu (Sassari, Italy), L. Terranova (Milan, Italy), M. Oriano (Milan, Italy), N. Vanoni (Milan, Italy), F. Amati (Milan, Italy), G. Pizzamiglio (Milan, Italy), M. Di Pasquale (Milan, Italy), S. Dellafiore (Milan, Italy), M. Pappalettera (Milan, Italy), B. Assael (Milan, Italy), F. Blasi (Milan, Italy)
| |
Sputum and plasma adiponectin levels in clinically stable adult cystic fibrosis patients with CFTR I1234V mutation
A. Abdul Wahab (Doha, Qatar), M. Allangawi (Doha, Qatar), M. Thomas (Doha, Qatar), I. Bettahi (Doha, Qatar), S. Silvaraman (Doha, Qatar), J. Kumar (Doha, Qatar), P. Chandra (Doha, Qatar), M. Ramanjaneya (Doha, Qatar)
| |
Implementing the International Committee on Mental Health in Cystic Fibrosis (ICMH) Guidelines: Practical complexities of managing mental health
M. Verkleij (Amsterdam, Netherlands), J. Boekhoff (Amsterdam, Netherlands), E. Haarman (Amsterdam, Netherlands), I. Bon (Amsterdam, Netherlands), A. Nagelkerke (Amsterdam, Netherlands), J. Abbott (Preston, United Kingdom)
| |
Coping in adult cystic fibrosis patients: Association with anxiety and depression
N. Uslu (Istanbul, Turkey), S. Olgun Yildizeli (Istanbul, Turkey), D. Kocakaya (Istanbul, Turkey), E. Eryüksel (Istanbul, Turkey), B. Ceyhan (Istanbul, Turkey)
| |